ACIU
AC Immune Ltd
NASDAQ: ACIU · HEALTHCARE · BIOTECHNOLOGY
$2.97
-1.33% today
Updated 2026-05-06
Market cap
$303.29M
P/E ratio
—
P/S ratio
84.88x
EPS (TTM)
$-0.84
Dividend yield
—
52W range
$2 – $4
Volume
0.3M
AC Immune Ltd (ACIU) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
-0.3%
Last 4 quarters
Revenue YoY growth
+13.0%
Most recent quarter
EPS YoY growth
+21.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-0.3%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+7.9%
2025-11-04
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-04-23 | $-0.15 | -7.1% | $3.06 | $2.84 | -7.2% |
| 2026-03-12 | $-0.14 | +10.5% | $3.06 | $3.02 | -1.5% |
| 2025-11-04 | $-0.16 | +15.8% | $3.18 | $3.43 | +7.9% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2026-03-31 | $-0.14 | $-0.15 | -7.1% | $1.12M | +13.0% |
| 2025-12-31 | $-0.16 | $-0.14 | +10.5% | $338000.00 | -70.3% |
| 2025-09-30 | $-0.19 | $-0.16 | +15.8% | $939000.00 | -96.3% |
| 2025-06-30 | $-0.17 | $-0.21 | -20.6% | $1.31M | +90.1% |
| 2025-03-31 | $-0.21 | $-0.19 | +8.2% | $990000.00 | +44.1% |
| 2024-12-31 | $-0.19 | $-0.16 | +15.9% | $1.14M | -92.3% |
| 2024-09-30 | $-0.23 | $0.06 | +126.1% | $25.48M | — |
| 2024-06-30 | $0.27 | $-0.23 | -185.2% | $687000.00 | — |
| 2024-03-31 | $-0.14 | $-0.18 | -28.6% | $687000.00 | — |
| 2023-12-31 | $-0.11 | $-0.05 | +54.5% | $14.80M | — |
| 2023-09-30 | $0.03 | $-0.18 | -700.0% | — | — |
| 2023-06-30 | $-0.19 | $-0.20 | -5.3% | — | — |
Frequently asked questions
Has AC Immune Ltd beaten earnings estimates?
AC Immune Ltd has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of -0.3% over the last 4 quarters.
How does ACIU stock react to earnings?
ACIU stock has moved an average of -0.3% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is AC Immune Ltd's revenue growth rate?
AC Immune Ltd reported year-over-year revenue growth of +13.0% in its most recent quarter, with EPS growing +21.1% year-over-year.